<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2012.2137</article-id>
<article-id pub-id-type="publisher-id">or-29-02-0791</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>The novel focal adhesion gene kindlin-2 promotes the invasion of gastric cancer cells mediated by tumor-associated macrophages</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>SHEN</surname><given-names>ZHANLONG</given-names></name><xref rid="af1-or-29-02-0791" ref-type="aff">1</xref><xref rid="af2-or-29-02-0791" ref-type="aff">2</xref><xref rid="fn1-or-29-02-0791" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>YE</surname><given-names>YINGJIANG</given-names></name><xref rid="af1-or-29-02-0791" ref-type="aff">1</xref><xref rid="fn1-or-29-02-0791" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>KAUTTU</surname><given-names>TUULI</given-names></name><xref rid="af2-or-29-02-0791" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>SEPP&#x000C4;NEN</surname><given-names>HANNA</given-names></name><xref rid="af2-or-29-02-0791" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>VAINIONP&#x000C4;&#x000C4;</surname><given-names>SANNA</given-names></name><xref rid="af2-or-29-02-0791" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>SHAN</given-names></name><xref rid="af1-or-29-02-0791" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>MUSTONEN</surname><given-names>HARRI</given-names></name><xref rid="af2-or-29-02-0791" ref-type="aff">2</xref><xref rid="fn2-or-29-02-0791" ref-type="author-notes">&#x0002A;&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>PUOLAKKAINEN</surname><given-names>PAULI</given-names></name><xref rid="af2-or-29-02-0791" ref-type="aff">2</xref><xref rid="fn2-or-29-02-0791" ref-type="author-notes">&#x0002A;&#x0002A;</xref><xref ref-type="corresp" rid="c1-or-29-02-0791"/></contrib></contrib-group>
<aff id="af1-or-29-02-0791">
<label>1</label>Department of Gastroenterological Surgery, Peking University People&apos;s Hospital, Beijing 100044, P.R. China</aff>
<aff id="af2-or-29-02-0791">
<label>2</label>Department of Surgery, Helsinki University Central Hospital, and University of Helsinki, Helsinki 00290, Finland</aff>
<author-notes>
<corresp id="c1-or-29-02-0791"><italic>Correspondence to:</italic> Dr Pauli Puolakkainen, Department of Surgery, Helsinki University Central Hospital, and University of Helsinki, Helsinki 00290, Finland, E-mail: <email>pauli.puolakkainen@hus.fi</email>. Dr Shan Wang, Department of Gastroenterological Surgery, Peking University People&apos;s Hospital, Beijing 100044, P.R. China, E-mail: <email>wangshan@yahoo.com.cn</email></corresp><fn id="fn1-or-29-02-0791">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn><fn id="fn2-or-29-02-0791">
<label>&#x0002A;&#x0002A;</label>
<p>Joint senior authorship</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2013</year></pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>11</month>
<year>2012</year></pub-date>
<volume>29</volume>
<issue>2</issue>
<fpage>791</fpage>
<lpage>797</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>08</month>
<year>2012</year></date>
<date date-type="accepted">
<day>20</day>
<month>09</month>
<year>2012</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2013, Spandidos Publications</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Kindlin-2 is a novel focal adhesion gene mediating the cell-extracellular matrix (ECM) adhesion. Tumor-associated macrophages (TAMs) play an important role in linking chronic inflammation to cancer progression. Both kindlin-2 and TAMs have been found to promote the invasion of gastric cancer cells in our previous studies. However, the correlation between kindlin-2 and TAMs remains unclear. Real-time RT-PCR was used to investigate kindlin-2 expression in the AGS, NCI and Hs-746T gastric cancer cell lines co-cultured with TAMs under normal or hypoxic conditions. IL8, IL10, IL11, IL17b, IL18, IL22 and IL24 expressions were measured by real-time RT-PCR in the gastric cancer lines with varying levels of kindlin-2 expression, as well as after downregulation of kindlin-2 mRNA expression by the siRNA method. We found that kindlin-2 was upregulated in all three gastric cancer cell lines when co-cultured with TAMs under normal conditions. Under hypoxic conditions, the induction of kindlin-2 expression induced by macrophages was significantly downregulated in the Hs-746T cell line. IL8, IL11, IL17b, IL22 and IL24 expression was significantly higher in gastric cell lines with high kindlin-2 expression. Downregulation of kindlin-2 mRNA decreased IL10, IL11, IL17b, IL22 and IL24 expression but IL8 and IL18 expression was upregulated. Therefore, the novel focal adhesion gene kindlin-2 may play an important role in promoting the invasion of gastric cancer cells mediated by TAMs through regulating interleukin expression.</p></abstract>
<kwd-group>
<kwd>kindlin-2</kwd>
<kwd>tumor-associated macrophages</kwd>
<kwd>interleukin</kwd>
<kwd>gastric cancer</kwd>
<kwd>invasion</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Kindlin-2 is a member of the focal adhesion protein family recruited to integrin-containing adhesion sites (<xref rid="b1-or-29-02-0791" ref-type="bibr">1</xref>&#x02013;<xref rid="b3-or-29-02-0791" ref-type="bibr">3</xref>). Kindlin-2 is localized to cell-extracellular matrix (ECM) adhesion sites, and has been shown to interact directly with the cytoplasmic tail of &#x003B2;1 and &#x003B2;3-integrin. Kindlin-2 overexpression has been shown to induce a modest activation of the &#x003B1;IIb&#x003B2;3-integrin (<xref rid="b4-or-29-02-0791" ref-type="bibr">4</xref>). Integrin-mediated cell adhesion triggers intracellular signaling pathways that control migration, proliferation, survival, and differentiation of cells including cancer cells (<xref rid="b5-or-29-02-0791" ref-type="bibr">5</xref>). Although kindlin-2 has been confirmed as an essential element of bidirectional integrin signaling (<xref rid="b6-or-29-02-0791" ref-type="bibr">6</xref>), little is known about the expression of kindlin-2 in association with human cancer. Recent studies have shown that kindlin-2 was differentially expressed in prostate, uterine leiomyosarcoma and malignant mesothelioma (<xref rid="b7-or-29-02-0791" ref-type="bibr">7</xref>&#x02013;<xref rid="b9-or-29-02-0791" ref-type="bibr">9</xref>). In our previous study, we found that kindlin-2 was upregulated at both the RNA and protein levels in gastric cancer tissues. Moreover, kindlin-2 expression had a significant positive correlation with tumor stromal invasion, lymph node metastasis and TNM stage. Patients with high kindlin-2 expression had significantly poorer overall survival and progression free survival. Thus, kindlin-2 might play an important role in the invasion and metastasis of gastric cancer.</p>
<p>Chronic inflammation has been linked to the development of cancer (<xref rid="b10-or-29-02-0791" ref-type="bibr">10</xref>). Individuals with ulcerative colitis, which is a chronic inflammatory disease of the colon, have a 10-fold increase in likelihood of developing colorectal carcinoma. Similarly, inflammatory conditions of the liver, such as chronic hepatitis and cirrhosis, are well established risk factors for the development of hepatocellular carcinoma (<xref rid="b11-or-29-02-0791" ref-type="bibr">11</xref>). Tumor-associated macrophages (TAMs) have been highlighted to play an important role in malignant progression of neoplasm (<xref rid="b12-or-29-02-0791" ref-type="bibr">12</xref>,<xref rid="b13-or-29-02-0791" ref-type="bibr">13</xref>). For many tumors, high numbers of TAMs correlate with lymph node involvement or the formation of distant metastases (<xref rid="b14-or-29-02-0791" ref-type="bibr">14</xref>,<xref rid="b15-or-29-02-0791" ref-type="bibr">15</xref>). Clinical studies have shown a correlation between the high number of TAMs in the areas of tumors and increased microvessel density and poor prognosis (<xref rid="b16-or-29-02-0791" ref-type="bibr">16</xref>&#x02013;<xref rid="b18-or-29-02-0791" ref-type="bibr">18</xref>). Our previous study showed that the TAMs play a role in regulating invasion and metastasis in gastric cancer cells. However, the molecular mechanism underlying the link between the inflammation mediated by macrophages and gastric cancer remains unclear.</p>
<p>Although both kindlin-2 and macrophages have been shown to be correlated with the invasion and metastasis of gastric cancer in our previous studies, we do not know whether the kindlin-2 gene is involved in the inflammatory process of promoting invasion of gastric cancer cells.</p>
<p>IL8, IL10, IL11 have been found to be expressed in gastric cancer (<xref rid="b19-or-29-02-0791" ref-type="bibr">19</xref>&#x02013;<xref rid="b21-or-29-02-0791" ref-type="bibr">21</xref>), but the expressions of IL17b, IL22 and IL24 in gastric cancer remain undefined. Moreover, so far there have been no reports on the relationship between inflammatory factors and kindlin-2 expression. In our study, we found that the kindlin-2 gene was not only significantly elevated when the gastric cancer cells were co-cultured with TAMs, but this elevation could also be induced by hypoxia. Furthermore, the interleukin expressions, with the exception of IL11, were significantly changed following kindlin-2 downregulation.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Isolation of monocytes and macrophages</title>
<p>Mononuclear cells were isolated from the blood of healthy subjects with density gradient centrifugation (Ficol-Paque; Amersham, Uppsala, Sweden). There were three layers of liquid after density gradient centrifugation, mononuclear cells were in the second cloudy layer, and it was transferred to a clean tube and centrifuged. The cells were washed with PBS&#x0002B;10&#x00025; ACD (acid citrate dextrose solution) solution two times. The cells were counted and 1.4&#x000D7;10<sup>6</sup> cells were placed on Matrigel (BD Biosciences, San Jose, CA, USA) covered coverslip (Nalge Nunc International Corp., Naperville, IL, USA). The isolated cells were grown in serum-free medium designed for macrophages (Macrophage serum free medium; Gibco, Paislay, UK) with granulocyte-macrophage colony-stimulating factor (GM-CSF, 10 ng/ml; ImmunoTools, Oldenburg, Germany), antibiotics and 5&#x00025; CO<sub>2</sub> at 37&#x000B0;C. Monocytes adhered to the Matrigel overnight and differentiated to macrophages due to GM-CSF; other non-adherent mononuclear cells were removed from the medium the following day. Monocytes were fully differentiated into macrophages after six days and then used for experiments. When co-cultured with cancer cells, macrophages developed into TAMs with special surface marker, CD14<sup>&#x0002B;</sup>(<xref rid="b22-or-29-02-0791" ref-type="bibr">22</xref>). After co-culturing with gastric cancer cells, the portion of CD14<sup>&#x0002B;</sup> positive macrophages reached &gt;80&#x00025; measured with flow cytometry.</p></sec>
<sec>
<title>Gastric cancer cell culture</title>
<p>The AGS cell line (CRL-1739) derived from fragments of a tumor resected from gastric cancer patients, was purchased from ATCC (American Type Culture Collection). The cells were cultured in Ham&apos;s F12K medium with 2 mM L-glutamine adjusted to contain 1.5 g/l sodium bicarbonate, 10&#x00025; fetal bovine serum (FBS) and antibiotics (100 &#x003BC;g/ml penicillin and 100 U/ml streptomycin).</p>
<p>The Hs 746T (HTB-135) cell line was purchased from ATCC. It was derived from a metastatic tumor of the left leg of a gastric cancer patient. Cells were cultured in Dulbecco&apos;s modified Eagle&apos;s medium (DMEM) with 4 mM L-glutamine adjusted to contain 1.5 g/l bicarbonate, 4.5 g/l glucose, 10&#x00025; FBS and antibiotics (100 &#x003BC;g/ml penicillin and 100 U/ml streptomycin).</p>
<p>The NCI-N87 (CRL-5822) cell line was derived from the metastatic liver tumor of a gastric cancer patient. It was purchased from ATCC. Cells were cultured in RPMI-1640 medium, supplemented with 10&#x00025; FBS and antibiotics (100 &#x003BC;g/ml penicillin and 100 U/ml streptomycin).</p>
<p>All gastric cancer cell lines were maintained at 37&#x000B0;C in a humidified atmosphere with 5&#x00025; CO<sub>2</sub>.</p></sec>
<sec>
<title>Cell sorting by magnetic separation</title>
<p>Cell sorting was performed after gastric cancer cells were cultured with macrophages for 24 h. Cell sorting was processed by MACS separator (MACS Miltenyi Biotec, Germany), which is based on magnetic separation. After Matrigel contained cells were dissolved and centrifuged, 80 &#x003BC;l of Buffer (degassed PBS with 0.5&#x00025; BSA and 2 mM EDTA) and 20 &#x003BC;l CD14 MicroBeads (MACS Miltenyi Biotec) were added to the deposit and incubated for 20 min at 4&#x000B0;C. Then the cells were washed by Buffer and centrifuged. Cells resuspended with Buffer were transferred to the prepared LS column (MACS Miltenyi Biotec). Total effluents which contained gastric cancer cells and CD14 negative macrophages were collected and centrifuged. The cell pellets were resuspended in buffer and CD11b MicroBeads, and the above mentioned separating protocol was repeated.</p></sec>
<sec>
<title>Invasion and migration assay (3D dynamic migration imaging system)</title>
<p>Cells were grown on Matrigel covered coverslip wells with serum-free medium designed for macrophages. Gastric cancer cells were grown either alone or with differentiated macrophages on Matrigel and either in normal (5&#x00025; CO<sub>2</sub> in air) or hypoxic conditions (CO<sub>2</sub> 5&#x00025;, O<sub>2</sub> 2&#x00025;, N<sub>2</sub> 94&#x00025;). Gastric cancer cells (6&#x000D7;10<sup>4</sup>) were seeded in each well of the coverslip. Gastric cancer cells were stained with fluorescent dye (CellTracker green CMFDA; Invitrogen, Eugene, OR, USA) before imaging. During the invasion phase the cancer cells invaded in Matrigel were imaged by 3D dynamic migration imaging system (Olympus Ax70 Research System Microscope, Japan; 12Bit Cooled Imaging Sensicam camera; PCD Imaging, Kelheim, Germany). The average migration speed was calculated from the cells which could be tracked at least for 6 h in one z-plane (ImagePro Plus; Media Cybernetics, Inc., Bethesda, MD, USA).</p></sec>
<sec>
<title>Real-time RT-PCR</title>
<p>Total-RNA was isolated from the sorted cells by membrane binding (RNeasy Mini kit, 74104; Qiagen, Hilden, Germany). RNA was reverse transcribed to single stranded cDNA by the reverse transcriptase method (High Capacity cDNA Reverse Transcription kit, 4368814; Applied Biosystems, Bardburg, NJ, USA). The target gene expression was measured by the real-time RT-PCR method (TaqMan Gene Expression Assay; Applied Biosystems). GAPDH was used as endogenic control (TaqMan Endogenous Controls; Applied Biosystems). The PCR reactions were run in ABI PRISM 7000 sequence detection system. 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> referred to the fold of the mRNA expression of one sample compared to the calibration sample. 2<sup>&#x02212;&#x00394;Ct</sup> was defined as the fold of mRNA expression of the target gene compared to GAPDH expression in the same sample.</p></sec>
<sec>
<title>Western blotting</title>
<p>Gastric cancer cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mmol/l Tris-Cl, 150 mmol/l NaCl, 1&#x00025; NP-40, 0.5&#x00025; sodium deoxycholate, and 0.1&#x00025; sodium dodecyl sulfate, pH 7.5) containing 1 mmol/l phenylmethylsulfonyl fluoride for 30 min on ice. The samples were centrifuged and the protein concentrations for each sample were determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). The protein samples (20 g) were separated by 10&#x00025; sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, and then electrotransferred to a nitrocellulose membrane. After blocking with 5&#x00025; nonfat dry milk in Tween-Tris-buffered saline solution &#x0005B;0.1&#x00025; Tween-20 in 100 mmol/l Tris-Cl (pH 7.5), 0.9&#x00025; NaCl&#x0005D;, the membranes were incubated with antibody to kindlin-2 (ab74030; Abcam, USA) at a dilution of 1:600 at 4&#x000B0;C overnight. After washing, the blots were incubated with horseradish peroxidase conjugated secondary antibodies at a dilution of 1:10,000 for kindlin-2 for 1 h. The blot was washed and developed using chemiluminescence (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). For control, we also blotted the membranes with primary antibodies against &#x003B2;-actin (sc-47778; Santa Cruz Biotechnology, Inc.) and densitometric data of kindlin-2 were normalized to those of &#x003B2;-actin levels.</p></sec>
<sec>
<title>siRNA transfection</title>
<p>In a 6-well tissue culture plate, 2&#x000D7;10<sup>5</sup> Hs-746T cells/well were seeded in 2 ml antibiotic-free DMEM medium supplemented with FBS. The cells were incubated at 37&#x000B0;C until the cells were 60&#x02013;80&#x00025; confluent. siRNA transfection kit (sc-45064; Santa Cruz Biotechnology, Inc.) was used to downregulate the expression. The cells were divided into three groups: blank control group, negative control group, and kindlin-2 siRNA group. Six microliters of kindlin-2 siRNA duplex (sc-10676) or control siRNA duplex (sc-37007) were added into 100 &#x003BC;l siRNA transfection medium (sc-36868) (all were from Santa Cruz Biotechnology, Inc.) as the kindlin-2 siRNA group or negative control group, respectively. In the blank control group, 6 &#x003BC;l transfection medium was used instead of duplex. For each transfection group, 6 &#x003BC;l siRNA transfection (sc-29528; Santa Cruz Biotechnology, Inc.) reagent was added into 100 &#x003BC;l siRNA transfection medium. Thereafter, they were mixed gently and incubated for 45 min at room temperature. The cells were washed once with 2 ml siRNA transfection medium. Then the mixed solution was overlaid the washed cells and incubated for 7 h in a CO<sub>2</sub> incubator. Subsequently, 1 ml DMEM medium containing 2-fold the normal serum and antibiotics concentration was added without removing the transfection mixture. The cells were incubated for an additional 24 h. The medium was replaced with normal DMEM medium the next day. The RNA of cells was extracted after 24 h.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Statistical package for social science (SPSS) version 17.0 was used. Data are expressed as the means &#x000B1; SEM. One way ANOVA was used to compare the cell movement speed data and mRNA expression data between different groups. P&lt;0.05 was considered to indicate statistically significant differences.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Kindlin-2 relative expression in gastric cancer cell lines</title>
<p>Kindlin-2 mRNA relative expression (kindlin-2/GAPDH) was higher in metastatic gastric cancer cell lines than in the non-metastatic gastric cancer cell line. Kindlin-2 mRNA expression was the highest in the Hs-746T cell line (658.4&#x000B1;4.8), and the lowest in the AGS cell line (2.3&#x000B1;0.6). Kindlin-2 mRNA relative expression in the NCI-N87 cell line was 81.8&#x000B1;4.3 (N&#x0003D;6) (<xref rid="f1-or-29-02-0791" ref-type="fig">Fig. 1</xref>). Kindlin-2 expression in protein level was verified by western blot analysis (<xref rid="f2-or-29-02-0791" ref-type="fig">Fig. 2</xref>).</p></sec>
<sec>
<title>Effect of TAMs on kindlin-2 expression in gastric cancer cell lines under normal or hypoxic conditions</title>
<p>Both kindlin-2 mRNA and protein were upregulated in all three gastric cancer cell lines, when co-cultured with macrophages under normal conditions. The elevation of kindlin-2 expression was significantly higher in the non-metastatic cell line AGS than in the two other cell lines.</p>
<p>Under hypoxic conditions, the induction of kindlin-2 expression by macrophages was significantly downregulated in all cell lines; AGS (P&lt;0.001), NCI-N87 (P&lt;0.001) and Hs-746T (P&#x0003D;0.013) (N&#x0003D;6) (<xref rid="tI-or-29-02-0791" ref-type="table">Table I</xref>). The effect of macrophage and hypoxia on kindlin-2 expression in protein level were in accordance with mRNA results (<xref rid="f2-or-29-02-0791" ref-type="fig">Fig. 2</xref>).</p></sec>
<sec>
<title>Expression of interleukin in gastric cancer cell lines with variable kindlin-2 expression</title>
<p>IL8, IL11, IL17b, IL24 expressions were the lowest in the AGS cell line which also had the lowest kindlin-2 expression, and the highest in the Hs-746T cell line, which had the highest kindlin-2 expression. There was a significant correlation between kindlin-2 and interleukin expression, with the exception of IL10 and IL18 (N&#x0003D;6) (<xref rid="tII-or-29-02-0791" ref-type="table">Table II</xref>). IL22 expression was significantly higher the in Hs-746T cell line than in the other two cell lines. IL18 and IL10 expressions were significantly lower in the metastatic cell lines compared to AGS (<xref rid="tIII-or-29-02-0791" ref-type="table">Table III</xref>).</p></sec>
<sec>
<title>Invasion rate of Hs-746T cells in Matrigel after downregulation of kindlin-2</title>
<p>The cell invasion rates in Matrigel decreased significantly following downregulation of kindlin-2 (3.2&#x000B1;0.1 &#x003BC;m/h) compared to the blank control group (3.9&#x000B1;0.3 &#x003BC;m/h, P&lt;0.001) and the negative control group (4.0&#x000B1;0.1 &#x003BC;m/h, P&lt;0.001, N&#x0003D;3).</p></sec>
<sec>
<title>Expression of interleukin in the Hs-746 cell line following downregulation of kindlin-2</title>
<p>As kindlin-2 relative expression was the highest in the Hs-746T cell line, we chose to downregulate kindlin-2 expression in this cell line. Real-time RT-PCR was used to verify the effect of kindlin-2 siRNA. We found that the level of mRNA expression in the kindlin-2 siRNA group (7.6&#x000B1;0.1) was significantly lower than in the negative control group (25.3&#x000B1;0.2) or in the blank control group (24.7&#x000B1;0.1), and there was no significant difference between the negative control and the blank control group (N&#x0003D;6) (<xref rid="f3-or-29-02-0791" ref-type="fig">Fig. 3</xref>).</p>
<p>IL8 and IL18 expressions were significantly elevated following downregulation of kindlin-2 expression in the Hs-746T cell line compared to the blank control group. IL10, IL11, IL17b, IL22 and IL24 expressions were significantly decreased after downregulation of kindlin-2 expression (N&#x0003D;6) (<xref rid="tIV-or-29-02-0791" ref-type="table">Table IV</xref>).</p></sec>
<sec>
<title>Correlation between interleukin expression and invasion rate in Matrigel following downregulation of kindlin-2</title>
<p>There was a significantly negative correlation between IL8, IL18 expression and gastric cancer cell migration rate in the Hs-746T cell line following downregualtion of kindlin-2 expression. (r&#x0003D;&#x02212;0.987, P&lt;0.001; r&#x0003D;&#x02212;0.983, P&lt;0.001). There was a significantly positive correlation between IL10, IL11, IL17b, IL22 and IL24 expression and cell migration rate (r&#x0003D;0.842, P&#x0003D;0.036; r&#x0003D;0.922, P&lt;0.001; r&#x0003D;0.920, P&#x0003D;0.009; r&#x0003D;0.974, P&#x0003D;0.001).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In recent years, studies of kindlin-2 as an important regulator of integrin activation have focused on the transformation and progression of tumors. In our two previous studies, we found that both kindlin-2 expression and chronic inflammation mediated by macrophages had an effect on the invasion of gastric cancer. However, little is known about the relationship between kindlin-2 expression and chronic inflammation. In this study, we found that kindlin-2 expression was upregulated by macrophages in all three gastric cancer cell lines. We speculated that kindlin-2 is involved in the process of tumor-associated inflammation, and tumor-associated macrophages (TAMs) could increase the invasion of cancer cells by enhancing the adhesion between cancer cells and extra-cellular matrix dependent on kindlin-2 upregulation.</p>
<p>The presence of multiple areas of hypoxia is a hallmark of cancer. A number of recent studies have shown that macrophages respond to the level of hypoxia in tumors by upregulating such transcription factors as hypoxia-inducible factors 1 and 2, which in turn activate a broad array of mitogenic, proinvasive, proangiogenic, and prometastatic genes (<xref rid="b23-or-29-02-0791" ref-type="bibr">23</xref>). However, so far there have been no reports about the relationship between kindlin-2 expression, hypoxia and macrophages. In our study, we found that the response of kindlin-2 expression to the hypoxia with macrophages depended on the gastric cancer cell lines and it was downregulated most severely in the metastatic cell line.</p>
<p>Significant results have demonstrated that inflammation cytokines, especially interleukin, play an important role in chronic inflammation and cancer progression (<xref rid="b24-or-29-02-0791" ref-type="bibr">24</xref>). Although kindlin-2 expression was found to be induced by TAMs in our study, we did not know the relationship between kindlin-2 and interleukins in the cancer cells. IL8 expression has been found in various human types of cancer including gastric cancer (<xref rid="b25-or-29-02-0791" ref-type="bibr">25</xref>). It has been implicated in a variety of cellular processes, especially in angiogenesis through stimulation of endothelial cell migration and suppression of programmed cell death (<xref rid="b26-or-29-02-0791" ref-type="bibr">26</xref>). In our study, IL8 was significantly elevated following downregulation of kindlin-2 expression with invasion rate in Matrigel decreased, suggesting that kindlin-2 might inhibit gastric cancer cell invasion through elevated IL8 expression. However, IL8 expression was high in the cell line with high kindlin-2 expression, which might be due to other signal pathways involved in the regulation of IL8 expression.</p>
<p>Data concerning the level of IL10 in gastric cancer patients display discrepancy. A study performed on 68 patients showed no correlation between serum IL10 level and the clinical course of disease (<xref rid="b27-or-29-02-0791" ref-type="bibr">27</xref>). On the other hand, Szaflarska <italic>et al</italic>(<xref rid="b28-or-29-02-0791" ref-type="bibr">28</xref>) reported that IL10 was elevated mostly in advanced disease and the increased levels were associated with significantly poorer survival of patients. Based on our results, we speculate that IL10 expression might depend on the type of gastric cancer and although its expression is low in the metastatic cell line with high kindlin-2 expression, downregulation of kindlin-2 might decrease the invasion of gastric cells through decreasing further IL10 expression.</p>
<p>IL11 was initially cloned as a mediator of plasmacytoma cell proliferation (<xref rid="b29-or-29-02-0791" ref-type="bibr">29</xref>) and was later found to exhibit a wide variety of biological effects in neural cells as well as in the hematopoietic and the immune systems (<xref rid="b30-or-29-02-0791" ref-type="bibr">30</xref>). It has previously been shown that expression of IL11 and its co-receptor were required for signal transduction and correlates with invasion and proliferation in gastric, and colorectal cancer (<xref rid="b20-or-29-02-0791" ref-type="bibr">20</xref>,<xref rid="b31-or-29-02-0791" ref-type="bibr">31</xref>). We found that IL11 expression was not only high in the gastric cancer cell line with high kindlin-2 expression, but was also significantly decreased after inferring kindlin-2 mRNA expression and was positively correlated with invasion rate in Matrigel, suggesting a positive role of kindlin-2 signaling in IL11 expression for regulating gastric cancer cell invasion.</p>
<p>IL18 has been shown to have potent antitumor effects that are mediated by the induction of apoptosis and inhibition of angiogenesis (<xref rid="b32-or-29-02-0791" ref-type="bibr">32</xref>,<xref rid="b33-or-29-02-0791" ref-type="bibr">33</xref>). However, some reports suggest that tumors could counterattack the immune system by secreting IL18 (<xref rid="b34-or-29-02-0791" ref-type="bibr">34</xref>). The serum IL18 concentration was reported to be higher in metastatic cancer patients than in early cancer patients (<xref rid="b35-or-29-02-0791" ref-type="bibr">35</xref>). We found that IL18 was not only weakly expressed in the metastatic cell line with high kindlin-2 expression, but its expression was also significantly increased after downregulation of kindlin-2. Therefore, kindlin-2 might contribute to the invasion of cancer cells through downregulation of IL18 expression, when macrophages interact with gastric cancer cells.</p>
<p>There are no previous reports on IL17b, IL22 and IL24 expression in gastric cancer. In this study, we found that these genes were expressed in three gastric cancer cell lines. Their expression correlated with kindlin-2 expression levels suggesting a role in promoting the invasion of gastric cancer cells. Moreover, downregulation of kindlin-2 expression induced a decrease in expression of these three interleukins. Therefore, kindlin-2 might be involved in the interaction between chronic inflammation and gastric cancer through positive regulation of 17b, IL22 and IL24 expression.</p>
<p>In conclusion, the novel adhesion gene kindlin-2 might play a role in promoting the invasion and metastasis of gastric cancer cells by TAMs and through regulating the expression of interleukins, such as IL8, IL10, IL11, IL17b, IL22 and IL24.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was supported by grants from the Sigrid Juselius Foundation and the Helsinki University Central Hospital Research Funds.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-or-29-02-0791"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogalski</surname><given-names>TM</given-names></name><name><surname>Mullen</surname><given-names>GP</given-names></name><name><surname>Gilbert</surname><given-names>MM</given-names></name><name><surname>Williams</surname><given-names>BD</given-names></name><name><surname>Moerman</surname><given-names>DG</given-names></name></person-group><article-title>The UNC-112 gene in <italic>Caenorhabditis elegans</italic> encodes a novel component of cell-matrix adhesion structures required for integrin localization in the muscle cell membrane</article-title><source>J Cell Biol</source><volume>150</volume><fpage>253</fpage><lpage>264</lpage><year>2000</year></element-citation></ref>
<ref id="b2-or-29-02-0791"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegener</surname><given-names>KL</given-names></name><name><surname>Partridge</surname><given-names>AW</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><etal/></person-group><article-title>Structural basis of integrin activation by talin</article-title><source>Cell</source><volume>128</volume><fpage>171</fpage><lpage>182</lpage><year>2007</year></element-citation></ref>
<ref id="b3-or-29-02-0791"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ussar</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>HV</given-names></name><name><surname>Linder</surname><given-names>S</given-names></name><name><surname>F&#x000E4;ssler</surname><given-names>R</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name></person-group><article-title>The Kindlins: subcellular localization and expression during murine development</article-title><source>Exp Cell Res</source><volume>312</volume><fpage>42</fpage><lpage>51</lpage><year>2006</year></element-citation></ref>
<ref id="b4-or-29-02-0791"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>YQ</given-names></name><name><surname>Tu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The MIG-2/integrin interaction strengthens cell-matrix adhesion and modulates cell motility</article-title><source>J Biol Chem</source><volume>282</volume><fpage>20455</fpage><lpage>20466</lpage><year>2007</year></element-citation></ref>
<ref id="b5-or-29-02-0791"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Carman</surname><given-names>CV</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins</article-title><source>Science</source><volume>301</volume><fpage>1720</fpage><lpage>1725</lpage><year>2003</year></element-citation></ref>
<ref id="b6-or-29-02-0791"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montanez</surname><given-names>E</given-names></name><name><surname>Ussar</surname><given-names>S</given-names></name><name><surname>Schifferer</surname><given-names>M</given-names></name><name><surname>B&#x000F6;sl</surname><given-names>M</given-names></name><name><surname>Zent</surname><given-names>R</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>F&#x000E4;ssler</surname><given-names>R</given-names></name></person-group><article-title>Kindlin-2 controls bidirectional signaling of integrins</article-title><source>Genes Dev</source><volume>22</volume><fpage>1325</fpage><lpage>1330</lpage><year>2008</year></element-citation></ref>
<ref id="b7-or-29-02-0791"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>Z</given-names></name><name><surname>Dobra</surname><given-names>K</given-names></name><name><surname>Lock</surname><given-names>JG</given-names></name><name><surname>Str&#x000F6;mblad</surname><given-names>S</given-names></name><name><surname>Hjerpe</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration</article-title><source>Int J Cancer</source><volume>127</volume><fpage>1999</fpage><lpage>2008</lpage><year>2010</year></element-citation></ref>
<ref id="b8-or-29-02-0791"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>X</given-names></name><name><surname>An</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Kindlin-2 controls sensitivity of prostate cancer cells to cisplatin-induced cell death</article-title><source>Cancer Lett</source><volume>299</volume><fpage>54</fpage><lpage>62</lpage><year>2010</year></element-citation></ref>
<ref id="b9-or-29-02-0791"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Shiozawa</surname><given-names>T</given-names></name><name><surname>Mitsushita</surname><given-names>J</given-names></name><etal/></person-group><article-title>Expression of the mitogen-inducible gene-2 (mig-2) is elevated in human uterine leiomyomas but not in leiomyosarcomas</article-title><source>Hum Pathol</source><volume>35</volume><fpage>55</fpage><lpage>60</lpage><year>2004</year></element-citation></ref>
<ref id="b10-or-29-02-0791"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sgambato</surname><given-names>A</given-names></name><name><surname>Cittadini</surname><given-names>A</given-names></name></person-group><article-title>Inflammation and cancer: a multifaceted link</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>14</volume><fpage>263</fpage><lpage>268</lpage><year>2010</year></element-citation></ref>
<ref id="b11-or-29-02-0791"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagemann</surname><given-names>T</given-names></name><name><surname>Balkwill</surname><given-names>F</given-names></name><name><surname>Lawrence</surname><given-names>T</given-names></name></person-group><article-title>Inflammation and cancer: a double-edged sword</article-title><source>Cancer Cell</source><volume>12</volume><fpage>300</fpage><lpage>301</lpage><year>2007</year></element-citation></ref>
<ref id="b12-or-29-02-0791"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhtar</surname><given-names>RA</given-names></name><name><surname>Nseyo</surname><given-names>O</given-names></name><name><surname>Campbell</surname><given-names>MJ</given-names></name><name><surname>Esserman</surname><given-names>LJ</given-names></name></person-group><article-title>Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics</article-title><source>Expert Rev Mol Diagn</source><volume>11</volume><fpage>91</fpage><lpage>100</lpage><year>2011</year></element-citation></ref>
<ref id="b13-or-29-02-0791"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>BC</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>ZG</given-names></name><name><surname>Wang</surname><given-names>BC</given-names></name><name><surname>Gao</surname><given-names>JF</given-names></name></person-group><article-title>Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma</article-title><source>Med Oncol</source><volume>28</volume><fpage>1447</fpage><lpage>1452</lpage><year>2011</year></element-citation></ref>
<ref id="b14-or-29-02-0791"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Ohno</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><etal/></person-group><article-title>Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer</article-title><source>Anticancer Res</source><volume>24</volume><fpage>3335</fpage><lpage>3342</lpage><year>2004</year></element-citation></ref>
<ref id="b15-or-29-02-0791"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanada</surname><given-names>T</given-names></name><name><surname>Nakagawa</surname><given-names>M</given-names></name><name><surname>Emoto</surname><given-names>A</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Nasu</surname><given-names>N</given-names></name><name><surname>Nomura</surname><given-names>Y</given-names></name></person-group><article-title>Prognostic value of tumor-associated macrophage count in human bladder cancer</article-title><source>Int J Urol</source><volume>7</volume><fpage>263</fpage><lpage>269</lpage><year>2000</year></element-citation></ref>
<ref id="b16-or-29-02-0791"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>RD</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name><name><surname>Whitehouse</surname><given-names>R</given-names></name><name><surname>Greenall</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>AL</given-names></name></person-group><article-title>Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma</article-title><source>Cancer Res</source><volume>56</volume><fpage>4625</fpage><lpage>4629</lpage><year>1996</year></element-citation></ref>
<ref id="b17-or-29-02-0791"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>H</given-names></name><name><surname>Sangai</surname><given-names>T</given-names></name><name><surname>Ishii</surname><given-names>G</given-names></name><etal/></person-group><article-title>Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression</article-title><source>Int J Cancer</source><volume>125</volume><fpage>1276</fpage><lpage>1284</lpage><year>2009</year></element-citation></ref>
<ref id="b18-or-29-02-0791"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>F</given-names></name><name><surname>Kageyama</surname><given-names>Y</given-names></name><name><surname>Kawakami</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer</article-title><source>J Urol</source><volume>171</volume><fpage>1080</fpage><lpage>1084</lpage><year>2004</year></element-citation></ref>
<ref id="b19-or-29-02-0791"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajkumar</surname><given-names>T</given-names></name><name><surname>Vijayalakshmi</surname><given-names>N</given-names></name><name><surname>Gopal</surname><given-names>G</given-names></name><name><surname>Sabitha</surname><given-names>K</given-names></name><name><surname>Shirley</surname><given-names>S</given-names></name><name><surname>Raja</surname><given-names>UM</given-names></name><name><surname>Ramakrishnan</surname><given-names>SA</given-names></name></person-group><article-title>Identification and validation of genes involved in gastric tumorigenesis</article-title><source>Cancer Cell Int</source><volume>10</volume><fpage>45</fpage><year>2010</year></element-citation></ref>
<ref id="b20-or-29-02-0791"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>CB</given-names></name><name><surname>Judd</surname><given-names>LM</given-names></name><name><surname>Menheniott</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression</article-title><source>J Pathol</source><volume>213</volume><fpage>140</fpage><lpage>151</lpage><year>2007</year></element-citation></ref>
<ref id="b21-or-29-02-0791"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>HH</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KA</given-names></name></person-group><article-title>Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians</article-title><source>Cytokine</source><volume>51</volume><fpage>73</fpage><lpage>77</lpage><year>2010</year></element-citation></ref>
<ref id="b22-or-29-02-0791"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Sozzani</surname><given-names>S</given-names></name><name><surname>Locati</surname><given-names>M</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name><name><surname>Sica</surname><given-names>A</given-names></name></person-group><article-title>Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes</article-title><source>Trends Immunol</source><volume>23</volume><fpage>549</fpage><lpage>555</lpage><year>2002</year></element-citation></ref>
<ref id="b23-or-29-02-0791"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>C</given-names></name><name><surname>Murdoch</surname><given-names>C</given-names></name></person-group><article-title>Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies</article-title><source>Am J Pathol</source><volume>167</volume><fpage>627</fpage><lpage>635</lpage><year>2005</year></element-citation></ref>
<ref id="b24-or-29-02-0791"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culig</surname><given-names>Z</given-names></name></person-group><article-title>Cytokine disbalance in common human cancers</article-title><source>Biochim Biophys Acta</source><volume>1813</volume><fpage>308</fpage><lpage>314</lpage><year>2011</year></element-citation></ref>
<ref id="b25-or-29-02-0791"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Mark</surname><given-names>SD</given-names></name><etal/></person-group><article-title>Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma</article-title><source>Cancer Epidemiol Biomarkers Prev</source><volume>13</volume><fpage>2251</fpage><lpage>2257</lpage><year>2004</year></element-citation></ref>
<ref id="b26-or-29-02-0791"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waugh</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name></person-group><article-title>The interleukin-8 pathway in cancer</article-title><source>Clin Cancer Res</source><volume>14</volume><fpage>6735</fpage><lpage>6741</lpage><year>2008</year></element-citation></ref>
<ref id="b27-or-29-02-0791"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thong-Ngam</surname><given-names>D</given-names></name><name><surname>Tangkijvanich</surname><given-names>P</given-names></name><name><surname>Lerknimitr</surname><given-names>R</given-names></name><name><surname>Mahachai</surname><given-names>V</given-names></name><name><surname>Theamboonelrs</surname><given-names>A</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name></person-group><article-title>Diagnostic role of serum interleukin-18 in gastric cancer patients</article-title><source>World J Gastroenterol</source><volume>12</volume><fpage>4473</fpage><lpage>4477</lpage><year>2006</year></element-citation></ref>
<ref id="b28-or-29-02-0791"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szaflarska</surname><given-names>A</given-names></name><name><surname>Szczepanik</surname><given-names>A</given-names></name><name><surname>Siedlar</surname><given-names>M</given-names></name><name><surname>Czupryna</surname><given-names>A</given-names></name><name><surname>Sierzega</surname><given-names>M</given-names></name><name><surname>Popiela</surname><given-names>T</given-names></name><name><surname>Zembala</surname><given-names>M</given-names></name></person-group><article-title>Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer</article-title><source>Anticancer Res</source><volume>29</volume><fpage>5005</fpage><lpage>5012</lpage><year>2009</year></element-citation></ref>
<ref id="b29-or-29-02-0791"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>SR</given-names></name><name><surname>Bennett</surname><given-names>F</given-names></name><name><surname>Calvetti</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine</article-title><source>Proc Natl Acad Sci USA</source><volume>87</volume><fpage>7512</fpage><lpage>7516</lpage><year>1990</year></element-citation></ref>
<ref id="b30-or-29-02-0791"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Williams</surname><given-names>DA</given-names></name></person-group><article-title>Interleukin-11: review of molecular, cell biology, and clinical use</article-title><source>Blood</source><volume>89</volume><fpage>3897</fpage><lpage>3908</lpage><year>1997</year></element-citation></ref>
<ref id="b31-or-29-02-0791"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Yoshizaki</surname><given-names>A</given-names></name><name><surname>Izumida</surname><given-names>S</given-names></name><etal/></person-group><article-title>Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells</article-title><source>Int J Oncol</source><volume>30</volume><fpage>825</fpage><lpage>833</lpage><year>2007</year></element-citation></ref>
<ref id="b32-or-29-02-0791"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okano</surname><given-names>F</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name></person-group><article-title>Canine interleukin-18 induces apoptosis and enhances Fas ligand mRNA expression in a canine carcinoma cell line</article-title><source>Anticancer Res</source><volume>20</volume><fpage>3411</fpage><lpage>3415</lpage><year>2000</year></element-citation></ref>
<ref id="b33-or-29-02-0791"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coughlin</surname><given-names>CM</given-names></name><name><surname>Salhany</surname><given-names>KE</given-names></name><name><surname>Wysocka</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis</article-title><source>J Clin Invest</source><volume>101</volume><fpage>1441</fpage><lpage>1452</lpage><year>1998</year></element-citation></ref>
<ref id="b34-or-29-02-0791"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><etal/></person-group><article-title>Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates</article-title><source>Cancer Res</source><volume>60</volume><fpage>2703</fpage><lpage>2709</lpage><year>2000</year></element-citation></ref>
<ref id="b35-or-29-02-0791"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lissoni</surname><given-names>P</given-names></name><name><surname>Brivio</surname><given-names>F</given-names></name><name><surname>Rovelli</surname><given-names>F</given-names></name><etal/></person-group><article-title>Serum concentrations of interleukin-18 in early and advanced cancer patients: enhancedsecretion in metastatic disease</article-title><source>J Biol Regul Homeost Agents</source><volume>14</volume><fpage>275</fpage><lpage>277</lpage><year>2000</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-or-29-02-0791" position="float">
<label>Figure 1</label>
<caption>
<p>Kindlin-2 expression in gastric cancer cell lines.</p></caption>
<graphic xlink:href="OR-29-02-0791-g00.gif"/></fig>
<fig id="f2-or-29-02-0791" position="float">
<label>Figure 2</label>
<caption>
<p>Effect of macrophages on the kindlin-2 expression under normal and hypoxic conditions (western blotting results). Kindlin-2 was upregulated in the three gastric cancer cell lines when co-cultured with macrophages under normal conditions. The elevation of kindlin-2 expression was the highest in the AGS cell line and the lowest in the Hs-746T cell line. Under hypoxic conditions, the induction of kindlin-2 expression by macrophages was significantly downregulated in all three cell lines, but in Hs-746T the downregulation was decreased even more than in the two other cell lines.</p></caption>
<graphic xlink:href="OR-29-02-0791-g01.gif"/></fig>
<fig id="f3-or-29-02-0791" position="float">
<label>Figure 3</label>
<caption>
<p>Kindlin-2 expression was downregulated in the kindlin-2 siRNA group compared to the other groups. There was no difference in kindlin-2 expression between the blank control and the negative control group.</p></caption>
<graphic xlink:href="OR-29-02-0791-g02.gif"/></fig>
<table-wrap id="tI-or-29-02-0791" position="float">
<label>Table I</label>
<caption>
<p>Effect of macrophages on the kindlin-2 expression in gastric cancer cell lines under normal or hypoxic conditions.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th colspan="4" align="center" valign="bottom">Kindlin-2 mRNA relative expression (2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>)</th></tr>
<tr>
<th align="left" valign="bottom"/>
<th colspan="4" align="left" valign="bottom">
<hr/></th></tr>
<tr>
<th align="left" valign="bottom"/>
<th align="center" valign="bottom">Cultured with/without macrophages under normal conditions</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">Cultured with macrophages under hypoxic/normal conditions (x10<sup>&#x02212;2</sup>)</th>
<th align="center" valign="bottom">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">AGS</td>
<td align="center" valign="top">4789.6&#x000B1;149.3</td>
<td align="center" valign="top"/>
<td align="center" valign="top">7.1&#x000B1;0.2</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">NCI-N87</td>
<td align="center" valign="top">455.1&#x000B1;9.5</td>
<td align="center" valign="top">P&lt;0.001<xref rid="tfn1-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">5.8&#x000B1;0.0</td>
<td align="center" valign="top">0.159</td></tr>
<tr>
<td align="left" valign="top">Hs-746T</td>
<td align="center" valign="top">157.7&#x000B1;6.6</td>
<td align="center" valign="top">P&lt;0.001<xref rid="tfn1-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">0.5&#x000B1;0.2</td>
<td align="center" valign="top">0.036<xref rid="tfn1-or-29-02-0791" ref-type="table-fn">a</xref></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-or-29-02-0791">
<label>a</label>
<p>Significant at the P&lt;0.05 level compared to the AGS cell line (N&#x0003D;6).</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="tII-or-29-02-0791" position="float">
<label>Table II</label>
<caption>
<p>Correlation between kindlin-2 and interleukin expression.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th align="center" valign="bottom">Pearson&apos;s correlation co-efficient (r)</th>
<th align="center" valign="bottom">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">IL8</td>
<td align="center" valign="top">0.988</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn2-or-29-02-0791" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">IL10</td>
<td align="center" valign="top">&#x02212;0.308</td>
<td align="center" valign="top">0.553</td></tr>
<tr>
<td align="left" valign="top">IL11</td>
<td align="center" valign="top">0.996</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn2-or-29-02-0791" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">IL17b</td>
<td align="center" valign="top">0.919</td>
<td align="center" valign="top">0.010</td></tr>
<tr>
<td align="left" valign="top">IL18</td>
<td align="center" valign="top">&#x02212;0.712</td>
<td align="center" valign="top">0.113</td></tr>
<tr>
<td align="left" valign="top">IL22</td>
<td align="center" valign="top">0.990</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn2-or-29-02-0791" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">IL24</td>
<td align="center" valign="top">0.993</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn2-or-29-02-0791" ref-type="table-fn">a</xref></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn2-or-29-02-0791">
<label>a</label>
<p>Significant at the P &lt;0.05 level.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="tIII-or-29-02-0791" position="float">
<label>Table III</label>
<caption>
<p>Relative expression of IL8, IL10, IL11, IL17b, IL18, IL22 and IL24 mRNA in gastric cancer cell lines.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th colspan="14" align="center" valign="bottom">mRNA relative expression (target gene/GAPDH, 2<sup>&#x02212;&#x00394;Ct</sup>)</th></tr>
<tr>
<th align="left" valign="bottom"/>
<th colspan="14" align="left" valign="bottom">
<hr/></th></tr>
<tr>
<th align="left" valign="bottom"/>
<th align="center" valign="bottom">IL8 (x10<sup>&#x02212;4</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL10 (x10<sup>&#x02212;5</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL11 (x10<sup>&#x02212;4</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL17b (x10<sup>&#x02212;7</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL18 (x10<sup>&#x02212;4</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL22 (x10<sup>&#x02212;7</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL24 (x10<sup>&#x02212;7</sup>)</th>
<th align="center" valign="bottom">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">AGS</td>
<td align="center" valign="top">2.1&#x000B1;0.1</td>
<td align="center" valign="top"/>
<td align="center" valign="top">8.3&#x000B1;0.6</td>
<td align="center" valign="top"/>
<td align="center" valign="top">1.4&#x000B1;0.2</td>
<td align="center" valign="top"/>
<td align="center" valign="top">4.7&#x000B1;0.1</td>
<td align="center" valign="top"/>
<td align="center" valign="top">23.7&#x000B1;0.9</td>
<td align="center" valign="top"/>
<td align="center" valign="top">3.6&#x000B1;0.1</td>
<td align="center" valign="top"/>
<td align="center" valign="top">4.8&#x000B1;0.1</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">NCI-N87</td>
<td align="center" valign="top">13.9&#x000B1;0.4</td>
<td align="center" valign="top">0.066</td>
<td align="center" valign="top">4.4&#x000B1;0.0</td>
<td align="center" valign="top">0.004<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">3.0&#x000B1;0.1</td>
<td align="center" valign="top">0.245<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">13.6&#x000B1;0.0</td>
<td align="center" valign="top">0.990</td>
<td align="center" valign="top">5.6&#x000B1;0.2</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">4.6&#x000B1;0.1</td>
<td align="center" valign="top">0.908</td>
<td align="center" valign="top">70.9&#x000B1;2.5</td>
<td align="center" valign="top">0.862</td></tr>
<tr>
<td align="left" valign="top">Hs-746T</td>
<td align="center" valign="top">55.4&#x000B1;5.1</td>
<td align="center" valign="top">0.001<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">3.9&#x000B1;0.2</td>
<td align="center" valign="top">0.002<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">37.9&#x000B1;1.3</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">2336.5&#x000B1;764.4</td>
<td align="center" valign="top">0.033</td>
<td align="center" valign="top">2.5&#x000B1;0.0</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">187.4&#x000B1;10.3</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">8464.4&#x000B1;428.9</td>
<td align="center" valign="top">&lt;0.001<xref rid="tfn3-or-29-02-0791" ref-type="table-fn">a</xref></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn3-or-29-02-0791">
<label>a</label>
<p>Significant at the P&lt;0.05 level compared to the AGS cell line (N&#x0003D;6).</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="tIV-or-29-02-0791" position="float">
<label>Table IV</label>
<caption>
<p>IL8, IL10, IL11, IL17b, IL18, IL22 and IL24 mRNA in the different groups of the Hs-746T gastric cancer cell line.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th colspan="14" align="center" valign="bottom">mRNA relative expression (target gene/GAPDH, 2<sup>&#x02212;&#x00394;Ct</sup>)</th></tr>
<tr>
<th align="left" valign="bottom"/>
<th colspan="14" align="left" valign="bottom">
<hr/></th></tr>
<tr>
<th align="left" valign="bottom"/>
<th align="center" valign="bottom">IL8 (x10<sup>&#x02212;4</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL10 (x10<sup>&#x02212;9</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL11 (x10<sup>&#x02212;4</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL17b (x10<sup>&#x02212;5</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL18 (x10<sup>&#x02212;5</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL22 (x10<sup>&#x02212;7</sup>)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">IL24 (x10<sup>&#x02212;5</sup>)</th>
<th align="center" valign="bottom">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Blank control</td>
<td align="center" valign="top">9.7&#x000B1;0.9</td>
<td align="center" valign="top"/>
<td align="center" valign="top">58.8&#x000B1;0.4</td>
<td align="center" valign="top"/>
<td align="center" valign="top">1.1&#x000B1;0.0</td>
<td align="center" valign="top"/>
<td align="center" valign="top">2.3&#x000B1;0.0</td>
<td align="center" valign="top"/>
<td align="center" valign="top">7.7&#x000B1;0.3</td>
<td align="center" valign="top"/>
<td align="center" valign="top">6.5&#x000B1;0.0</td>
<td align="center" valign="top"/>
<td align="center" valign="top">5.9&#x000B1;0.0</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">Negative control</td>
<td align="center" valign="top">7.7&#x000B1;0.1</td>
<td align="center" valign="top">0.116</td>
<td align="center" valign="top">47.2&#x000B1;2.6</td>
<td align="center" valign="top">0.350</td>
<td align="center" valign="top">1.5&#x000B1;0.0</td>
<td align="center" valign="top">0.055</td>
<td align="center" valign="top">2.1&#x000B1;0.0</td>
<td align="center" valign="top">0.507</td>
<td align="center" valign="top">7.2&#x000B1;0.1</td>
<td align="center" valign="top">0.344</td>
<td align="center" valign="top">6.3&#x000B1;0.0</td>
<td align="center" valign="top">0.150</td>
<td align="center" valign="top">5.6&#x000B1;0.0</td>
<td align="center" valign="top">0.114</td></tr>
<tr>
<td align="left" valign="top">Kindlin-2 siRNA</td>
<td align="center" valign="top">49.4&#x000B1;0.5</td>
<td align="center" valign="top">0.001<xref rid="tfn4-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">3.1&#x000B1;0.1</td>
<td align="center" valign="top">0.014<xref rid="tfn4-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">0.6&#x000B1;0.0</td>
<td align="center" valign="top">0.003</td>
<td align="center" valign="top">1.1&#x000B1;0.0</td>
<td align="center" valign="top">0.017<xref rid="tfn4-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">10.7&#x000B1;0.2</td>
<td align="center" valign="top">0.021<xref rid="tfn4-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">2.1&#x000B1;0.0</td>
<td align="center" valign="top">0.001<xref rid="tfn4-or-29-02-0791" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">3.8&#x000B1;0.0</td>
<td align="center" valign="top">0.001<xref rid="tfn4-or-29-02-0791" ref-type="table-fn">a</xref></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn4-or-29-02-0791">
<label>a</label>
<p>Significant at the P&lt;0.05 level compared to the blank control group (N&#x0003D;6).</p></fn></table-wrap-foot></table-wrap></floats-group></article>
